date:Nov 06, 2013
r Biochip Array Technology and ELISA products are based on specific antibodies for each individual Sulphonamide so this reduces reliance on cross-reactivity and increases accuracy.
Feedback from customers to date has been very positive, as investing in quality screening reduces false positives, and dramatically cuts associated costs with superfluous confirmatory testing.